TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice

Nature Medicine

Volumn 6, Issue 5, 2000, Pages 556-563

  Zhang, Dou ^a   Gaussin, Vinciane ^a   Taffet, George E ^a   Belaguli, Narasimhaswamy S ^a   Yamada, Miho ^a   Schwartz, Robert J ^a   Michael, Lloyd H ^a   Overbeek, Paul A ^a   Schneider, Michael D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHOTRANSFERASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE INDUCTION; GENE MUTATION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; MECHANICAL STRESS; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE;

NASA DISCIPLINE CARDIOPULMONARY; NASA PROGRAM BIOMEDICAL RESEARCH AND COUNTERMEASURES; NON-NASA CENTER;

ACTIVATING TRANSCRIPTION FACTOR 6; ANIMALS; AORTA; BLOOD PRESSURE; CARDIAC OUTPUT, LOW; CARDIOMEGALY; DIASTOLE; DNA-BINDING PROTEINS; DOWN-REGULATION; MALE; MAP KINASE KINASE KINASES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; NUCLEAR PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SERUM RESPONSE FACTOR; SIGNAL TRANSDUCTION; SYSTOLE; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; EUKARYOTA; MUS MUSCULUS;

EID: 0034105968     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/75037     Document Type: Article

References (45)

1. MacLellan, W.R. & Schneider, M.D. in Cardiac Development (eds. Harvey, R. & Rosenthal, N.) 405-427 (Academic Press, San Diego, 1998).
2. Sadoshima, J. & Izumo, S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59, 551-571 (1997).
3. MacLellan, W.R. & Schneider, M.D. Death by design -Programmed cell death in cardiovascular bioloqy and disease. Circ. Res. 81, 137-144 (1997).
4. Adams, J.W. et al. Enhanced G α q signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc. Natl. Acad. Sci. USA 95, 10140-10145 (1998).
5. Hirota, H. et al. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97, 189-198 (1999).
6. Wang, Y.B. et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273, 2161-2168 (1998).
7. Nemoto, S., Sheng, Z.L. & Lin, A.N. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol. Cell. Biol. 18, 3518-3526 (1998).
8. Yamaguchi, K. et al. Identification of a member of the MAPKKK family as a potential mediator ot TGF-β signal transduction. Science 270, 2008-2011 (1995).
9. Moriguchi, T. et al. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol. Chem. 271, 13675-13679 (1996).
10. Ninomiya-Tsuji, J. et al. The kinase TAK1 can activate the NIK-1 kappa B as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398, 252-256 (1999).
11. Villarreal, F.J. & Dillmann, W.H. Cardiac hypertrophy-induced changes in mRNA levels for TGF-β 1, fibronectin, and collagen. Am. J. Physiol. 262, H1861-1866 (1992).
12. Parker, T.G., Packer, S.E. & Schneider, M.D. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J. Clin. Invest, 85, 507-514 (1990).
13. Shirakabe, K. et al. TAK1 mediates the ceramide signaling to stress-activated protein kinase c-Jun N-terminal kinase. J. Biol. Chem. 272, 8141-8144 (1997).
14. Sano, Y. et al. ATF-2 Is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-β signaling. J. Biol. Chem. 274, 8949-8957 (1999).
15. Kretzschmar, M. & Massague, J. SMADs mediators and regulators of TGF-β signaling. Curr. Opin. Genet. Dev. 8, 103-111 (1998).
16. MacLellan, W.R., Lee, T.C., Schwartz, R.J. & Schneider, M.D. Transforming growth factor-beta response elements of the skeletal alpha-actin gene: Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. J. Biol. Chem. 269, 16754-16760 (1994).
17. Paradis, P., Maclellan, W.R., Belaguli, N.S., Schwartz, R.J. & Schneider, M.D. Serum response factor mediates AP-1-dependent induction of the skeletal α-actin promoter in ventricular myocytes. J. Biol. Chem. 271, 10827-10833 (1996).
18. Thuerauf, D.J. et al. p38 mitogen-activated protein kinase mediates the transcriptional induction of the atrial natriuretic factor gene through a serum response element. A potential role for the transcription factor ATF6. J. Biol. Chem. 273, 20636-20643 (1998).
19. Croissant, J.D. et al. Avian serum response factor expression restricted primarily to muscle cell lineages is required for α-actin gene transcription. Dev Biol 177, 250-264 (1996).
20. Chen, C.Y. & Schwartz, R.J. Recruitment of the tinman homolog nkx-2.5 by serum response factor activates cardiac α-actin gene transcription. Mol. Cell. Biol. 16, 6372-6384 (1996).
21. Zhu, C., Johansen, F.E. & Prywes, R. Interaction of ATF6 and serum response factor. Mol. Cell. Biol. 17, 4957-4966 (1997).
22. Raingeaud, J., Whitmarsh, A.J., Barrett, T., Derijard, B & Davis, R.J. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16, 1247-1255 (1996).
23. Boluyt, M.O. et al. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res 75, 23-32 (1994).
24. Molkentin, J.D. et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228 (1998).
25. Georgakopoulos, D. et al. The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation. Nature Med. 5, 327-330 (1999).
26. Taffet, G.E. et al. Noninvasive indexes of cardiac systolic and diastolic function in hyperthyroid and senescent mouse. Am. J. Physiol. 270, H2204-2209 (1996).
27. Hartley, C.J., Michael, L.H. & Entman, M.L. Noninvasive measurement of ascending aortic blood velocity in mice. Am. J. Physiol. 268, H499-505 (1995).
28. Brown, T.L., Patil, S., Cianci, C.D., Morrow, J.S. & Howe, P.H. Transforming growth factor β induces caspase 3-independent cleavage of αll-spectrin (α-todrin) coincident with apoptosis. J. Biol. Chem. 274, 23256-23262 (1999).
29. Yamazaki, T. et al. Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes. J. Clin. Invest. 96, 438-446 (1995).
30. Charng, M J. et al. A constitutive mutation of ALK5 disrupts cardiac looping and morphogenesis in mice. Dev. Biol. 199, 72-79 (1998).
31. Kapadia, S.R. et al. Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ. Res. 81, 187-195 (1997).
32. Shioi, T. et al. Increased expression of interleukin-1β and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the hypertrophied and failing heart with pressure overload. Circ. Res. 81, 664-671 (1997).
33. Monzen, K. et al. Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4. Mol. Cell. Biol. 19, 7096-7105 (1999).
34. Agah, R. et al. Gene recombination in postmitotic cells: Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Invest. 100, 169-179 (1997).
35. Abdellatif, M., MacLellan, W.R. & Schneider, M.D. p21 Ras as a governor of global gene expression. J. Biol. Chem. 269, 15423-15426 (1994).
36. Wrana, J.L. et al. TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71, 1003-1014 (1992).
37. Ornitz, D.M., Moreadith, R.W. & Leder, P. Binary system for regulating transgene expression in mice: targeting int-2 gene expression with yeast GAL4/UAS control elements. Proc. Natl. Acad. Sci. USA 88, 698-702 (1991).
38. Johansen, F.E. & Prywes, R. Identification of transcriptional activation and inhibitory domains in serum response factor (SRF) by using GAL4-SRF constructs. Mol. Cell. Biol. 13, 4640-4647 (1993).
39. Sadowski, I. & Ptashne, M. A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res. 17, 7539 (1989).
40. Jiang, W. & Hunter, T. Identification and characterization of a human protein kinase related to budding yeast Cdc7p. Proc. Natl. Acad. Sci. USA 94, 14320-14325 (1997).
41. Kirshenbaum, L.A., Abdellatif, M., Chakraborty, S. & Schneider, M.D. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev. Biol. 179, 402-411 (1996).
42. Subramaniam, A. et al. Tissue-specific regulation of the α-myosin heavy chain gene promoter in transgenic mice. J. Biol. Chem. 266, 24613-24620 (1991).
43. Depre, C. et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nature Med. 4, 1269-1275 (1998).
44. Ritter, S.J. & Davies, P.J.A Identification of a transforming growth factor-β 1/bone morphogenetic protein 4 (TGF-β1/BMP4) response element within the mouse tissue transglutaminase gene promoter. J. Biol. Chem. 273, 12798-12806 (1998).
45. Rindt, H., Gulick, J., Knotts, S., Neumann, J. & Robbins, J. In vivo analysis of the murine β-myosin heavy chain gene promoter. J. Biol. Chem. 268, 5332-5338 (1993).